Showing results (101-110 of 112) with videos related to
Sort By:
Pageof 12
Journal of the American College of Cardiology|June 1, 1995
Rapid arterial hemostasis and decreased access site complications after cardiac catheterization and angioplasty: results of a randomized trial of a novel hemostatic deviceW G Kussmaul, M Buchbinder, P L Whitlow, et al.Circulation|April 1, 1995
A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. CAVEAT-II InvestigatorsD R Holmes, E J Topol, R M Califf, et al.Journal of the American College of Cardiology|November 30, 1999
Relationship of extent of revascularization with angina at one year in the Bypass Angioplasty Revascularization Investigation (BARI)P L Whitlow, A P Dimas, T M Bashore, et al.Journal of the American College of Cardiology|December 1, 1992
Effect of Buckberg cardioplegia and peripheral cardiopulmonary bypass on infarct size in the closed chest dogJ H Frierson, M S Penn, A M Lafont, et al.Catheterization and Cardiovascular Diagnosis|February 1, 1995
Transluminal extraction catheter for the treatment of diseased saphenous vein grafts: a multicenter experienceT B Meany, M B Leon, B L Kramer, et al.Circulation|October 3, 2001
Long-term clinical outcomes after unprotected left main trunk percutaneous revascularization in 279 patientsW A Tan, H Tamai, S J Park, et al.The American Journal of Cardiology|February 11, 1992
Clinical angiographic and histologic correlates of ectasia after directional coronary atherectomyN B De Cesare, J J Popma, D R Holmes, et al.American Heart Journal|July 30, 1999
Clinical correlates of the initial and long-term cost of coronary bypass surgery and coronary angioplastyM A Hlatky, D B Boothroyd, M M Brooks, et al.The American Journal of Cardiology|November 15, 2000
Quality of life after coronary revascularization in the United States and CanadaM G Bourassa, M M Brooks, D B Mark, et al.The American Journal of Cardiology|October 6, 2000
Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockadeF A Cura, S R Kapadia, P L L'Allier, et al.Pageof 12